Fight for Sight: Choroideremia gene therapy gives long-term benefit to vision

3 May 2016
Source: Fight for Sight

Results from a 3.5-year follow-up study show that patients who took part in the world’s first gene therapy clinical trial for choroideremia have had a long-lasting benefit to their eyesight. The clinical trial was led by Professor Robert MacLaren at the University of Oxford and was made possible due to research by Professor Miguel Seabra at Imperial College London supported

Read more Fight for Sight: Choroideremia gene therapy gives long-term benefit to vision